Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Richter's Transformation × selinexor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 18 Recurrence 7 Leukemia, Myeloid, Acute 5 Neoplasms, Plasma Cell 4 Thymoma 2 Ovarian Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Carcinoma 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Smoldering Multiple Myeloma 1 Small Cell Lung Carcinoma 1 Sarcoma, Alveolar Soft Part 1 Richter's Transformation 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Oligodendroglioma 1 Neurofibrosarcoma 1 Neoplasms 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Melanoma 1 MDS 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Glioma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02138786 2023-01-26

SIRRT

Karyopharm Therapeutics Inc

Phase 2 Terminated

27 enrolled 17 charts

Richter's Transformation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡